SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899140-22-000493
Filing Date
2022-05-02
Accepted
2022-05-02 17:27:02
Documents
2
Period of Report
2022-04-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K i52714371a.htm 8-K 15013
2 OFFER LETTER BETWEEN INNOVIVA, INC. AND PAVEL RAIFELD, DATED APRIL 29, 2022 i5271437b.htm EX-10.1 21235
  Complete submission text file 0000899140-22-000493.txt   37676
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 22883416
SIC: 2834 Pharmaceutical Preparations